Michael E. Hagensee

1.5k total citations
44 papers, 1.2k citations indexed

About

Michael E. Hagensee is a scholar working on Epidemiology, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael E. Hagensee has authored 44 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 14 papers in Surgery and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael E. Hagensee's work include Cervical Cancer and HPV Research (28 papers), Genital Health and Disease (13 papers) and HIV/AIDS oral health manifestations (10 papers). Michael E. Hagensee is often cited by papers focused on Cervical Cancer and HPV Research (28 papers), Genital Health and Disease (13 papers) and HIV/AIDS oral health manifestations (10 papers). Michael E. Hagensee collaborates with scholars based in United States, Canada and Hong Kong. Michael E. Hagensee's co-authors include Jennifer Cameron, Patricia Kissinger, Anil K. Chaturvedi, Rebecca A. Clark, Janet E. Leigh, Jeanne Dumestre, Leann Myers, David H. Martin, Denise A. Galloway and Joeli Brinkman and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Clinical Microbiology.

In The Last Decade

Michael E. Hagensee

44 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Hagensee United States 22 798 363 258 192 188 44 1.2k
Giulia Ciccarese Italy 21 534 0.7× 136 0.4× 157 0.6× 146 0.8× 124 0.7× 100 1.2k
Dianne J. Marais South Africa 22 776 1.0× 346 1.0× 158 0.6× 100 0.5× 54 0.3× 31 934
Sandra O’Reilly United States 8 800 1.0× 429 1.2× 169 0.7× 105 0.5× 47 0.3× 8 959
G. Albero Italy 15 852 1.1× 487 1.3× 119 0.5× 169 0.9× 198 1.1× 27 1.2k
Eduardo Lazcano Mexico 16 885 1.1× 606 1.7× 100 0.4× 291 1.5× 142 0.8× 28 1.4k
Marı́a Alejandra Picconi Argentina 19 779 1.0× 331 0.9× 181 0.7× 229 1.2× 38 0.2× 59 1.1k
Bruce Allan South Africa 23 1.1k 1.4× 525 1.4× 268 1.0× 259 1.3× 47 0.3× 38 1.4k
Audrey J. King Netherlands 23 1.1k 1.4× 361 1.0× 691 2.7× 90 0.5× 131 0.7× 53 1.4k
Giuseppina Capra Italy 21 470 0.6× 291 0.8× 68 0.3× 107 0.6× 107 0.6× 52 994
Leah Beardsley United States 7 2.0k 2.5× 996 2.7× 381 1.5× 328 1.7× 126 0.7× 8 2.3k

Countries citing papers authored by Michael E. Hagensee

Since Specialization
Citations

This map shows the geographic impact of Michael E. Hagensee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Hagensee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Hagensee more than expected).

Fields of papers citing papers by Michael E. Hagensee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Hagensee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Hagensee. The network helps show where Michael E. Hagensee may publish in the future.

Co-authorship network of co-authors of Michael E. Hagensee

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Hagensee. A scholar is included among the top collaborators of Michael E. Hagensee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Hagensee. Michael E. Hagensee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hagensee, Michael E., et al.. (2023). Characteristics of Mpox Infections in Louisiana in the 2022 Outbreak. AIDS Research and Human Retroviruses. 39(11). 587–592. 1 indexed citations
2.
Hagensee, Michael E., et al.. (2023). Dynamics of Serum-Neutralizing Antibody Responses in Vaccinees through Multiple Doses of the BNT162b2 Vaccine. Vaccines. 11(11). 1720–1720. 8 indexed citations
3.
Tso, For Yue, et al.. (2023). Longitudinal Variations in Antibody Responses against SARS-CoV-2 Spike Epitopes upon Serial Vaccinations. International Journal of Molecular Sciences. 24(8). 7292–7292. 6 indexed citations
4.
Fidel, Paul L., Elizabeth A. Lilly, Shahr B. Hashmi, et al.. (2021). Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses. mBio. 12(2). 21 indexed citations
5.
6.
Griffen, Ann L., Clifford J. Beall, Elizabeth A. Lilly, et al.. (2019). Significant effect of HIV/HAART on oral microbiota using multivariate analysis. Scientific Reports. 9(1). 19946–19946. 25 indexed citations
7.
Cameron, Jennifer, Anne F. Rositch, Nadja A. Vielot, et al.. (2018). Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sexually Transmitted Diseases. 45(10). 666–672. 13 indexed citations
8.
Crosby, Richard A., Michael E. Hagensee, Rebecca Fisher, Lindsay R. Stradtman, & Tom Collins. (2016). Self-collected vaginal swabs for HPV screening: An exploratory study of rural Black Mississippi women. Preventive Medicine Reports. 7. 227–231. 6 indexed citations
9.
Crosby, Richard A., et al.. (2015). Community-Based Screening for Cervical Cancer. Sexually Transmitted Diseases. 42(11). 607–611. 27 indexed citations
10.
Johnson, Nadia, et al.. (2009). Development and Validation of a HPV-32 Specific PCR Assay. Virology Journal. 6(1). 90–90. 3 indexed citations
11.
Cameron, Jennifer & Michael E. Hagensee. (2008). Oral HPV complications in HIV-infected patients. Current HIV/AIDS Reports. 5(3). 126–131. 29 indexed citations
12.
Kissinger, Patricia, Angela M. Amedee, Rebecca A. Clark, et al.. (2008). Trichomonas Vaginalis Treatment Reduces Vaginal HIV-1 Shedding. Sexually Transmitted Diseases. 36(1). 11–16. 129 indexed citations
13.
Vo, Quynh N., Wan-Ju Kim, Andrew J. McWhorter, et al.. (2005). The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanisms. Oral Oncology. 41(10). 1013–1020. 46 indexed citations
14.
Kissinger, Patricia, Jeanne Dumestre, Rebecca A. Clark, et al.. (2005). Vaginal Swabs Versus Lavage for Detection of Trichomonas vaginalis and Bacterial Vaginosis Among HIV-Positive Women. Sexually Transmitted Diseases. 32(4). 227–230. 18 indexed citations
15.
Hagensee, Michael E., Rebecca A. Clark, Jennifer Cameron, & Janet E. Leigh. (2004). Human Papillomavirus Infection and Disease in HIV-Infected Individuals. The American Journal of the Medical Sciences. 328(1). 57–63. 75 indexed citations
16.
Thompson, Deborah, John M. Douglas, Mark P. Foster, et al.. (2004). Seroepidemiology of Infection with Human Papillomavirus 16, in Men and Women Attending Sexually Transmitted Disease Clinics in the United States. The Journal of Infectious Diseases. 190(9). 1563–1574. 51 indexed citations
17.
Chaturvedi, Anil K., Jeanne Dumestre, Rebecca A. Clark, et al.. (2004). Prevalence of human papillomavirus genotypes in women from three clinical settings. Journal of Medical Virology. 75(1). 105–113. 39 indexed citations
18.
Brinkman, Joeli, et al.. (2003). Optimization of PCR based detection of human papillomavirus DNA from urine specimens. Journal of Clinical Virology. 29(4). 230–240. 47 indexed citations
19.
Hagensee, Michael E., Joseph J. Carter, Gregory C. Wipf, & Denise A. Galloway. (1995). Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM,and mucosal IgA antibodies. Virology. 206(1). 174–182. 29 indexed citations
20.
Huseby, Jon S., et al.. (1991). Hyperthyroidism Induced by Iodinated Glycerol. American Review of Respiratory Disease. 144(6). 1403–1403. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Ciccarese Breakdown of academic impact, for papers by Dianne J. Marais Breakdown of academic impact, for papers by Sandra O’Reilly Breakdown of academic impact, for papers by G. Albero Breakdown of academic impact, for papers by Eduardo Lazcano Breakdown of academic impact, for papers by Marı́a Alejandra Picconi Breakdown of academic impact, for papers by Bruce Allan Breakdown of academic impact, for papers by Audrey J. King Breakdown of academic impact, for papers by Giuseppina Capra Breakdown of academic impact, for papers by Leah Beardsley
Rankless by CCL
2026